Loading...
FDA75F40126Q00155
Response Deadline
Jun 2, 2026, 5:00 PM(EDT)11 days
Eligibility
Contract Type
Special Notice
The FDA / Center for Drug Evaluation and Research (CDER) / Office of Pharmaceutical Quality Research (OPQR) requires to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies.
Please review the attached Intent to Sole Source FDA-75F40126Q00155 document for more information.
Terina Hicks
DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
FDA Office of Acquisitions and Grants Services
FDA Office of Acquisitions and Grants Services
5630 Fishers Lane
Rockville, MD, 20857
NAICS
Software Publishers
PSC
IT AND TELECOM - PLATFORM AS A SERVICE: DATABASE, MAINFRAME, MIDDLEWARE
Set-Aside
No Set aside used